Market Research Logo

Orthopedic Biomaterials Market Report Suite for US 2017-2023 | MedSuite (Includes 10 Reports)

Orthopedic Biomaterials Market Report Suite for US 2017-2023 | MedSuite (Includes 10 Reports)

The full report suite on the U.S. market for orthopedic biomaterials includes bone graft substitutes, which is represented by allografts, demineralized bone matrix, and synthetic bone graft market. The report also includes orthopedic growth factors, cellular allografts, orthopedic cell therapy, hyaluronic acid viscosupplementation, orthopedic cartilage repair, and spinal machined bone allograft markets.


EXECUTIVE SUMMARY
U.S. ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
U.S. DIAGNOSTIC OPHTHALMIC DEVICE MARKET OVERVIEW
2.1 INTRODUCTION
2.1.1 Bone Graft Substitutes
2.1.2 Growth Factors
2.1.3 Orthopedic Stem Cell Therapy
2.1.4 Cell Therapies
2.1.5 Hyaluronic Acid Viscosupplementation
2.1.6 Cartilage Repair
2.1.7 Spinal Machined Bone Allografts
2.2 MARKET OVERVIEW
2.3 TREND ANALYSIS BY SEGMENT
2.4 DRIVERS AND LIMITERS
2.4.1 Market Drivers
2.4.2 Market Limiters
2.5 COMPETITIVE MARKET SHARE ANALYSIS
2.6 HERFINDAHL INDEX
PROCEDURE NUMBERS
3.1 PROCEDURE DEFINITIONS
3.2 BONE GRAFT PROCEDURE NUMBERS BY TYPE
3.3 BONE GRAFT SUBSTITUTE PROCEDURE NUMBERS
3.3.1 By Material
3.3.2 By Indication
3.4 GROWTH FACTOR BONE GRAFT PROCEDURE NUMBERS
3.5 STEM CELL BONE GRAFT PROCEDURE NUMBERS
3.6 CELL THERAPY TREATMENT NUMBERS
3.6.1 Overview by Type
3.6.2 Platelet-Rich Treatment Numbers by Indication
3.6.3 Platelet-Rich Treatment Numbers by Indication
3.7 HYALURONIC ACID TREATMENT NUMBERS BY TYPE
3.8 CARTILAGE REPAIR PROCEDURE NUMBERS BY TYPE
3.9 SPINAL MACHINED BONE ALLOGRAFT PROCEDURE NUMBERS BY APPROACH
ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET
4.1 INTRODUCTION
4.1.1 Units Per Procedure by Indication
4.2 MARKET OVERVIEW
4.2.1 Bone Graft Substitute Market by Material
4.2.2 Bone Graft Substitute Market by Indication
4.3 MARKET ANALYSIS AND FORECAST
4.3.1 Total Orthopedic Bone Graft Substitute Market
4.3.2 Bone Graft Substitute Market by Material
4.3.2.1 Total Allograft Bone Graft Substitute Market
4.3.2.2 Allograft Bone Graft Substitute Market by Indication
4.3.2.2.1 Spine
4.3.2.2.2 Trauma
4.3.2.2.3 Large Joint Reconstruction
4.3.2.2.4 Foot Reconstruction
4.3.2.2.5 Craniomaxillofacial
4.3.2.2.6 Oncology
4.3.2.3 Total Demineralized Bone Matrix Market
4.3.2.4 Demineralized Bone Matrix Market with and without Carriers
4.3.2.5 Demineralized Bone Matrix Market by Indication
4.3.2.5.1 Spine
4.3.2.5.2 Trauma
4.3.2.5.3 Large Joint Reconstruction
4.3.2.5.4 Foot Reconstruction
4.3.2.5.5 Craniomaxillofacial
4.3.2.5.6 Oncology
4.3.2.6 Total Synthetic Bone Graft Substitute Market
4.3.2.7 Synthetic Bone Graft Substitute Market by Indication
4.3.2.7.1 Spine
4.3.2.7.2 Trauma
4.3.2.7.3 Large Joint Reconstruction
4.3.2.7.4 Foot Reconstruction
4.3.2.7.5 Craniomaxillofacial
4.3.2.7.6 Oncology
4.3.3 Bone Graft Substitute Market by Indication
4.3.3.1 Spine
4.3.3.1.1 Cervical Spine
4.3.3.1.2 Thoracolumbar Spine
4.3.3.2 Trauma
4.3.3.2.1 Non-Union Trauma
4.3.3.2.2 Fresh Fracture Trauma
4.3.3.3 Large Joint Reconstruction
4.3.3.3.1 Hip Large Joint Reconstruction
4.3.3.3.2 Knee Large Joint Reconstruction
4.3.3.4 Foot Reconstruction
4.3.3.5 Craniomaxillofacial
4.3.3.6 Oncology
4.4 DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE MARKET SHARE ANALYSIS
ORTHOPEDIC GROWTH FACTOR MARKET
5.1 INTRODUCTION
5.2 MARKET ANALYSIS AND FORECAST
5.3 DRIVERS AND LIMITERS
5.3.1 Market Drivers
5.3.2 Market Limiters
5.4 COMPETITIVE MARKET SHARE ANALYSIS
ORTHOPEDIC STEM CELL MARKET MARKET
6.1 INTRODUCTION
6.2 MARKET OVERVIEW
6.3 MARKET ANALYSIS AND FORECAST
6.3.1 Total Orthopedic Stem Cell Market
6.3.1.1 Cervical Spine Stem Cell Market
6.3.1.2 Lumbar Spine Stem Cell Market
6.4 DRIVERS AND LIMITERS
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 COMPETITIVE MARKET SHARE ANALYSIS
ORTHOPEDIC CELL THERAPY MARKET
7.1 INTRODUCTION
7.2 MARKET OVERVIEW
7.3 MARKET ANALYSIS AND FORECAST
7.3.1 Total Platelet-Rich Plasma Market
7.3.1.1 Soft Tissue Platelet-Rich Plasma Market
7.3.1.2 Orthopedic Platelet-Rich Plasma Market
7.3.1.3 Cardiac Platelet-Rich Plasma Market
7.3.1.4 Spine Platelet-Rich Plasma Market
7.3.1.5 Plastics Platelet-Rich Plasma Market
7.3.2 Total Bone Marrow Concentrate Market
7.3.2.1 Spine Bone Marrow Concentrate Market
7.3.2.2 Trauma Bone Marrow Concentrate Market
7.3.2.3 Soft Tissue Concentrated Bone Marrow Aspirate Market
7.3.2.4 Joint Concentration Bone Marrow Concentrate Market
7.4 DRIVERS AND LIMITERS
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 COMPETITIVE MARKET SHARE ANALYSIS
ORTHOPEDIC HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
8.1 INTRODUCTION
8.2 MARKET OVERVIEW
8.3 MARKET ANALYSIS AND FORECAST
8.3.1 Total Hyaluronic Acid Viscosupplementation Market
8.3.1.1 Single-Injection Hyaluronic Acid Viscosupplementation Market
8.3.1.2 Three-Injection Hyaluronic Acid Viscosupplementation Market
8.3.1.3 Five-Injection Hyaluronic Acid Viscosupplementation Market
8.4 DRIVERS AND LIMITERS
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 COMPETITIVE MARKET SHARE ANALYSIS
ORTHOPEDIC CARTILAGE REPAIR MARKET
9.1 INTRODUCTION
9.2 MARKET OVERVIEW
9.3 MARKET ANALYSIS AND FORECAST
9.3.1 Osteochondral Allograft Market
9.3.2 Meniscal Allograft Market
9.3.3 Autologous Chondrocyte Implantation Market
9.3.4 Particulated Juvenile Allograft Implant Market
9.3.5 Microfracture Adjunct Market
9.4 DRIVERS AND LIMITERS
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 COMPETITIVE MARKET SHARE ANALYSIS
SPINAL MACHINED BONE ALLOGRAFT MARKET
10.1 INTRODUCTION
10.2 MARKET OVERVIEW
10.3 MARKET ANALYSIS AND FORECAST
10.3.1 Total Spinal Machined Bone Allograft Market
10.3.2 ALIF Machined Bone Allograft Market
10.3.2.1 PLIF Machined Bone Allograft Market
10.3.2.2 TLIF Machined Bone Allograft Market
10.3.2.3 CIF Machined Bone Allograft Market
10.4 DRIVERS AND LIMITERS
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
List of Charts
Chart 1 1: Orthopedic Biomaterials Market by Segment, U.S., 2013 – 2023 19
Chart 1 2: Orthopedic Biomaterials Market Overview, U.S., 2013 & 2023 19
Chart 2 1: Orthopedic Biomaterials Market by Segment, U.S., 2013 – 2023 45
Chart 2 2: Orthopedic Biomaterials Market Breakdown, U.S., 2016 46
Chart 2 3: Orthopedic Biomaterials Market Breakdown, U.S., 2023 46
Chart 2 4: Growth Rates by Segment, Orthopedic Biomaterials Market, U.S., 2013 – 2023 49
Chart 2 5: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2016 54
Chart 3 1: Bone Graft Procedure Numbers by Type, U.S., 2013 – 2023 59
Chart 3 2: Bone Graft Substitute Procedure Numbers by Material, U.S., 2013 – 2023 62
Chart 3 3: Bone Graft Substitute Procedure Numbers by Indication, U.S., 2013 – 2023 66
Chart 3 4: Growth Factor Bone Graft Procedure Numbers, U.S., 2013 – 2023 68
Chart 3 5: Stem Cell Bone Graft Procedure Numbers, U.S., 2013 – 2023 70
Chart 3 6: Cell Therapy Treatment Numbers by Type, U.S., 2013 – 2023 72
Chart 3 7: Platelet-Rich Plasma Treatment Numbers by Indication, U.S., 2013 – 2023 75
Chart 3 8: Bone Marrow Concentrate Treatment Numbers by Indication, U.S., 2013 – 2023 78
Chart 3 9: Hyaluronic Acid Treatment Numbers by Type, U.S., 2013 – 2023 81
Chart 3 10: Cartilage Repair Procedure Numbers by Type, U.S., 2013 – 2023 84
Chart 3 11: Spinal Machined Bone Allograft Procedure Numbers by Approach, U.S., 2013 – 2023 87
Chart 4 1: Orthopedic Bone Graft Substitute Market by Material, U.S., 2013 – 2023 92
Chart 4 2: Orthopedic Bone Graft Substitute Market Breakdown by Material, U.S., 2016 93
Chart 4 3: Orthopedic Bone Graft Substitute Market Breakdown by Material, U.S., 2023 93
Chart 4 4: Orthopedic Bone Graft Substitute Market by Indication, U.S., 2013 – 2023 96
Chart 4 5: Orthopedic Bone Graft Substitute Market Breakdown by Indication, U.S., 2016 97
Chart 4 6: Orthopedic Bone Graft Substitute Market Breakdown by Indication, U.S., 2023 97
Chart 4 7: Total Orthopedic Bone Graft Substitute Market, U.S., 2013 – 2023 99
Chart 4 8: Total Allograft Bone Graft Substitute Market, U.S., 2013 – 2023 101
Chart 4 9: Allograft Bone Graft Substitute Market by Indication, U.S., 2013 – 2023 103
Chart 4 10: Total Spine Allograft Bone Graft Substitute Market, U.S., 2013 – 2023 105
Chart 4 11: Cervical Spine Bone Graft Substitute Market, U.S., 2013 – 2023 107
Chart 4 12: Thoracolumbar Spine Allograft Bone Graft Substitute Market, U.S., 2013 – 2023 109
Chart 4 13: Total Trauma Allograft Bone Graft Substitute Market, U.S., 2013 – 2023 111
Chart 4 14: Non-Union Trauma Allograft Bone Graft Substitute Market, U.S., 2013 – 2023 113
Chart 4 15: Fresh Fracture Trauma Allograft Bone Graft Substitute Market, U.S., 2013 – 2023 115
Chart 4 16: Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 – 2023 117
Chart 4 17: Hip Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 – 2023 119
Chart 4 18: Knee Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 – 2023 121
Chart 4 19: Foot Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 – 2023 123
Chart 4 20: Craniomaxillofacial Allograft Bone Graft Substitute Market, U.S., 2013 – 2023 125
Chart 4 21: Oncology Allograft Bone Graft Substitute Market, U.S., 2013 – 2023 127
Chart 4 22: Total Demineralized Bone Matrix Market, U.S., 2013 – 2023 129
Chart 4 23: Demineralized Bone Matrix Market by Indication, U.S., 2013 – 2023 132
Chart 4 24: Total Spine Demineralized Bone Matrix Market, U.S., 2013 – 2023 134
Chart 4 25: Cervical Spine Demineralized Bone Matrix Market, U.S., 2013 – 2023 136
Chart 4 26: Thoracolumbar Spine Demineralized Bone Matrix Market, U.S., 2013 – 2023 138
Chart 4 27: Total Trauma Demineralized Bone Matrix Market, U.S., 2013 – 2023 140
Chart 4 28: Non-Union Trauma Demineralized Bone Matrix Market, U.S., 2013 – 2023 142
Chart 4 29: Fresh Fracture Trauma Demineralized Bone Matrix Market, U.S., 2013 – 2023 144
Chart 4 30: Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 – 2023 146
Chart 4 31: Hip Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 – 2023 148
Chart 4 32: Knee Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 – 2023 150
Chart 4 33: Foot Reconstruction Demineralized Bone Matrix Market, U.S., 2013 – 2023 152
Chart 4 34: Craniomaxillofacial Demineralized Bone Matrix Market, U.S., 2013 – 2023 154
Chart 4 35: Oncology Demineralized Bone Matrix Market, U.S., 2013 – 2023 156
Chart 4 36: Total Orthopedic Bone Graft Substitute Market, U.S., 2013 – 2023 158
Chart 4 37: Synthetic Bone Graft Substitute Market by Indication, U.S., 2013 – 2023 160
Chart 4 38: Spine Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023 162
Chart 4 39: Cervical Spine Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023 164
Chart 4 40: Thoracolumbar Spine Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023 166
Chart 4 41: Total Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023 168
Chart 4 42: Non-Union Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023 170
Chart 4 43: Fresh Fracture Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023 172
Chart 4 44: Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023 174
Chart 4 45: Hip Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023 176
Chart 4 46: Knee Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023 178
Chart 4 47: Foot Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023 180
Chart 4 48: Craniomaxillofacial Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023 182
Chart 4 49: Oncology Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023 184
Chart 4 50: Spine Bone Graft Substitute Market, U.S., 2013 – 2023 186
Chart 4 51: Cervical Spine Bone Graft Substitute Market, U.S., 2013 – 2023 188
Chart 4 52: Thoracolumbar Spine Bone Graft Substitute Market, U.S., 2013 – 2023 190
Chart 4 53: Total Trauma Bone Graft Substitute Market, U.S., 2013 – 2023 192
Chart 4 54: Non-Union Trauma Bone Graft Substitute Market, U.S., 2013 – 2023 194
Chart 4 55: Fresh Fracture Trauma Bone Graft Substitute Market, U.S., 2013 – 2023 196
Chart 4 56: Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 – 2023 198
Chart 4 57: Hip Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 – 2023 200
Chart 4 58: Knee Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 – 2023 202
Chart 4 59: Foot Reconstruction Bone Graft Substitute Market, U.S., 2013 – 2023 204
Chart 4 60: Craniomaxillofacial Bone Graft Substitute Market, U.S., 2013 – 2023 206
Chart 4 61: Oncology Bone Graft Substitute Market, U.S., 2013 – 2023 208
Chart 4 62: Leading Competitors, Orthopedic Bone Graft Substitute Market, U.S., 2016 212
Chart 5 1: Orthopedic Growth Factor Market, U.S., 2013 – 2023 215
Chart 5 2: Leading Competitors, Orthopedic Growth Factor Market, U.S., 2016 219
Chart 6 1: Orthopedic Stem Cell Market by Segment, U.S., 2013 – 2023 223
Chart 6 2: Orthopedic Stem Cell Market Breakdown, U.S., 2016 224
Chart 6 3: Orthopedic Stem Cell Market Breakdown, U.S., 2023 224
Chart 6 4: Total Orthopedic Stem Cell Market, U.S., 2013 – 2023 226
Chart 6 5: Cervical Spine Stem Cell Market, U.S., 2013 – 2023 228
Chart 6 6: Lumbar Spine Stem Cell Market, U.S., 2013 – 2023 230
Chart 6 7: Leading Competitors, Orthopedic Stem Cell Market, U.S., 2016 234
Chart 7 1: Orthopedic Cell Therapy Market by Segment, U.S., 2013 – 2023 238
Chart 7 2: Orthopedic Cell Therapy Market Breakdown, U.S., 2016 239
Chart 7 3: Orthopedic Cell Therapy Market Breakdown, U.S., 2023 239
Chart 7 4: Total Platelet-Rich Plasma Market, U.S., 2013 – 2023 241
Chart 7 5: Soft Tissue Platelet-Rich Plasma Market, U.S., 2013 – 2023 243
Chart 7 6: Orthopedic Platelet-Rich Plasma Market, U.S., 2013 – 2023 245
Chart 7 7: Cardiac Platelet-Rich Plasma Market, U.S., 2013 – 2023 247
Chart 7 8: Spine Platelet-Rich Plasma Market, U.S., 2013 – 2023 249
Chart 7 9: Plastics Platelet-Rich Plasma Market, U.S., 2013 – 2023 251
Chart 7 10: Total Bone Marrow Concentrate Market, U.S., 2013 – 2023 253
Chart 7 11: Spine Bone Marrow Concentrate Market, U.S., 2013 – 2023 255
Chart 7 12: Trauma Bone Marrow Concentrate Market, U.S., 2013 – 2023 257
Chart 7 13: Soft Tissue Concentrated Bone Marrow Aspirate Market, U.S., 2013 – 2023 259
Chart 7 14: Joint Concentration Bone Marrow Concentrate Market, U.S., 2013 – 2023 261
Chart 7 15: Leading Competitors, Orthopedic Cell Therapy Market, U.S., 2016 265
Chart 8 1: Orthopedic Hyaluronic Acid Viscosupplementation Market by Segment, U.S., 2013 – 2023 269
Chart 8 2: Orthopedic Hyaluronic Acid Viscosupplementation Market Breakdown, U.S., 2016 270
Chart 8 3: Orthopedic Hyaluronic Acid Viscosupplementation Market Breakdown, U.S., 2023 270
Chart 8 4: Total Hyaluronic Acid Viscosupplementation Market, U.S., 2013 – 2023 272
Chart 8 5: Single-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 – 2023 274
Chart 8 6: Three-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 – 2023 276
Chart 8 7: Five-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 – 2023 278
Chart 8 8: Leading Competitors, Orthopedic Hyaluronic Acid Viscosupplementation Market, U.S., 2016 282
Chart 9 1: Orthopedic Cartilage Repair Market by Segment, U.S., 2013 – 2023 286
Chart 9 2: Orthopedic Cartilage Repair Market Breakdown, U.S., 2016 287
Chart 9 3: Orthopedic Cartilage Repair Market Breakdown, U.S., 2023 287
Chart 9 4: Osteochondral Allograft Market, U.S., 2013 – 2023 289
Chart 9 5: Meniscal Allograft Market, U.S., 2013 – 2023 291
Chart 9 6: Autologous Chondrocyte Implantation Market, U.S., 2013 – 2023 293
Chart 9 7: Particulated Juvenile Allograft Implant Market, U.S., 2013 – 2023 295
Chart 9 8: Microfracture Adjunct Market, U.S., 2013 – 2023 297
Chart 9 9: Leading Competitors, Orthopedic Cartilage Repair Market, U.S., 2016 301
Chart 10 1: Spinal Machined Bone Allograft Market by Segment, U.S., 2013 – 2023 305
Chart 10 2: Spinal Machined Bone Allograft Market Breakdown, U.S., 2016 306
Chart 10 3: Spinal Machined Bone Allograft Market Breakdown, U.S., 2023 306
Chart 10 4: Total Spinal Machined Bone Allograft Market, U.S., 2013 – 2023 308
Chart 10 5: ALIF Machined Bone Allograft Market, U.S., 2013 – 2023 310
Chart 10 6: PLIF Machined Bone Allograft Market, U.S., 2013 – 2023 312
Chart 10 7: TLIF Machined Bone Allograft Market, U.S., 2013 – 2023 314
Chart 10 8: CIF Machined Bone Allograft Market, U.S., 2013 – 2023 316
Chart 10 9: Leading Competitors, Spinal Machined Bone Allograft Market, U.S., 2016 320
List of Figures
Figure 1 1: Orthopedic Biomaterials Market Share Ranking by Segment, U.S., 2016 (1 of 2)
Figure 1 2: Orthopedic Biomaterials Market Share Ranking by Segment, U.S., 2016 (2 of 2)
Figure 1 3: Companies Researched in this Report, U.S., 2016
Figure 1 4: Factors Impacting the Orthopedic Biomaterials Market by Segment, U.S. (1 of 2)
Figure 1 5: Factors Impacting the Orthopedic Biomaterials Market by Segment, U.S. (2 of 2)
Figure 1 6: Recent Events in the Orthopedic Biomaterials Market, U.S., 2013 – 2016
Figure 1 7: Orthopedic Biomaterials Markets Covered, U.S., 2016
Figure 1 8: Procedure Codes Investigated, U.S., 2016
Figure 1 9: Orthopedic Biomaterials Markets Covered, U.S., 2016
Figure 1 10: Key Report Updates
Figure 1 11: Version History
Figure 2 1: Total Orthopedic Biomaterials Market, U.S., 2013 – 2023 (US$M)
Figure 2 2: Orthopedic Biomaterials Market by Segment, U.S., 2013 – 2023 (US$M) (1 of 2)
Figure 2 3: Orthopedic Biomaterials Market by Segment, U.S., 2013 – 2023 (US$M) (2 of 2)
Figure 2 4: Orthopedic Biomaterials Market Growth by Segment, U.S., 2013 – 2023
Figure 2 5: Drivers and Limiters, Orthopedic Biomaterials Market, U.S., 2016
Figure 2 6: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2016
Figure 2 7: Herfindahl Index, Orthopedic Biomaterials Market, U.S., 2016
Figure 3 1: Bone Graft Procedure Numbers by Type, U.S., 2013 – 2023
Figure 3 2: Bone Graft Substitute Procedure Numbers by Material, U.S., 2013 – 2023
Figure 3 3: Bone Graft Substitute Procedure Numbers by Indication, U.S., 2013 – 2023 (1 of 2)
Figure 3 4: Bone Graft Substitute Procedure Numbers by Indication, U.S., 2013 – 2023 (2 of 2)
Figure 3 5: Growth Factor Bone Graft Procedure Numbers, U.S., 2013 – 2023
Figure 3 6: Stem Cell Bone Graft Procedure Numbers, U.S., 2013 – 2023
Figure 3 7: Cell Therapy Treatment Numbers by Type, U.S., 2013 – 2023
Figure 3 8: Platelet-Rich Plasma Treatment Numbers by Indication, U.S., 2013 – 2023
Figure 3 9: Bone Marrow Concentrate Treatment Numbers by Indication, U.S., 2013 – 2023
Figure 3 10: Hyaluronic Acid Treatment Numbers by Type, U.S., 2013 – 2023
Figure 3 11: Cartilage Repair Procedure Numbers by Type, U.S., 2013 – 2023
Figure 3 12: Spinal Machined Bone Allograft Procedure Numbers by Approach, U.S., 2013 – 2023
Figure 4 1: Units per Procedure by Indication, Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 4 2: Orthopedic Bone Graft Substitute Market by Material, U.S., 2013 – 2023 (US$M)
Figure 4 3: Orthopedic Bone Graft Substitute Market by Indication, U.S., 2013 – 2023 (US$M)
Figure 4 4: Total Orthopedic Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 5: Total Allograft Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 6: Allograft Bone Graft Substitute Market by Indication, U.S., 2013 – 2023
Figure 4 7: Total Spine Allograft Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 8: Cervical Spine Allograft Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 9: Thoracolumbar Spine Allograft Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 10: Total Trauma Allograft Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 11: Non-Union Trauma Allograft Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 12: Fresh Fracture Trauma Allograft Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 13: Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 14: Hip Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 15: Knee Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 16: Foot Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 17: Craniomaxillofacial Allograft Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 18: Oncology Allograft Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 19: Total Demineralized Bone Matrix Market, U.S., 2013 – 2023
Figure 4 20: Demineralized Bone Matrix Market (with Carriers), U.S., 2013 – 2023
Figure 4 21: Demineralized Bone Matrix Market (without Carriers), U.S., 2013 – 2023
Figure 4 22: Demineralized Bone Matrix Market by Indication, U.S., 2013 – 2023
Figure 4 23: Total Spine Demineralized Bone Matrix Market, U.S., 2013 – 2023
Figure 4 24: Cervical Spine Demineralized Bone Matrix Market, U.S., 2013 – 2023
Figure 4 25: Thoracolumbar Spine Demineralized Bone Matrix Market, U.S., 2013 – 2023
Figure 4 26: Total Trauma Demineralized Bone Matrix Market, U.S., 2013 – 2023
Figure 4 27: Non-Union Trauma Demineralized Bone Matrix Market, U.S., 2013 – 2023
Figure 4 28: Fresh Fracture Trauma Demineralized Bone Matrix Market, U.S., 2013 – 2023
Figure 4 29: Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 – 2023
Figure 4 30: Hip Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 – 2023
Figure 4 31: Knee Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 – 2023
Figure 4 32: Foot Reconstruction Demineralized Bone Matrix Market, U.S., 2013 – 2023
Figure 4 33: Craniomaxillofacial Demineralized Bone Matrix Market, U.S., 2013 – 2023
Figure 4 34: Oncology Demineralized Bone Matrix Market, U.S., 2013 – 2023
Figure 4 35: Total Orthopedic Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 36: Synthetic Bone Graft Substitute Market by Indication, U.S., 2013 – 2023
Figure 4 37: Spine Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 38: Cervical Spine Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 39: Thoracolumbar Spine Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 40: Total Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 41: Non-Union Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 42: Fresh Fracture Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 43: Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 44: Hip Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 45: Knee Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 46: Foot Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 47: Craniomaxillofacial Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 48: Oncology Synthetic Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 49: Spine Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 50: Cervical Spine Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 51: Thoracolumbar Spine Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 52: Total Trauma Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 53: Non-Union Trauma Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 54: Fresh Fracture Trauma Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 55: Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 56: Hip Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 57: Knee Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 58: Foot Reconstruction Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 59: Craniomaxillofacial Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 60: Oncology Bone Graft Substitute Market, U.S., 2013 – 2023
Figure 4 61: Drivers and Limiters, Orthopedic Bone Graft Substitute Market, U.S., 2016
Figure 4 62: Leading Competitors, Orthopedic Bone Graft Substitute Market, U.S., 2016
Figure 5 1: Orthopedic Growth Factor Market, U.S., 2013 – 2023
Figure 5 2: Drivers and Limiters, Orthopedic Growth Factor Market, U.S., 2016
Figure 5 3: Leading Competitors, Orthopedic Growth Factor Market, U.S., 2016
Figure 6 1: Orthopedic Stem Cell Market by Segment, U.S., 2013 – 2023 (US$M)
Figure 6 2: Total Orthopedic Stem Cell Market, U.S., 2013 – 2023
Figure 6 3: Cervical Spine Stem Cell Market, U.S., 2013 – 2023
Figure 6 4: Lumbar Spine Stem Cell Market, U.S., 2013 – 2023
Figure 6 5: Drivers and Limiters, Orthopedic Stem Cell Market, U.S., 2016
Figure 6 6: Leading Competitors, Orthopedic Stem Cell Market, U.S., 2016
Figure 7 1: Orthopedic Cell Therapy Market by Segment, U.S., 2013 – 2023 (US$M)
Figure 7 2: Total Platelet-Rich Plasma Market, U.S., 2013 – 2023
Figure 7 3: Soft Tissue Platelet-Rich Plasma Market, U.S., 2013 – 2023
Figure 7 4: Orthopedic Platelet-Rich Plasma Market, U.S., 2013 – 2023
Figure 7 5: Cardiac Platelet-Rich Plasma Market, U.S., 2013 – 2023
Figure 7 6: Spine Platelet-Rich Plasma Market, U.S., 2013 – 2023
Figure 7 7: Plastics Platelet-Rich Plasma Market, U.S., 2013 – 2023
Figure 7 8: Total Bone Marrow Concentrate Market, U.S., 2013 – 2023
Figure 7 9: Spine Bone Marrow Concentrate Market, U.S., 2013 – 2023
Figure 7 10: Trauma Bone Marrow Concentrate Market, U.S., 2013 – 2023
Figure 7 11: Soft Tissue Concentrated Bone Marrow Aspirate Market, U.S., 2013 – 2023
Figure 7 12: Joint Concentration Bone Marrow Concentrate Market, U.S., 2013 – 2023
Figure 7 13: Drivers and Limiters, Orthopedic Cell Therapy Market, U.S., 2016
Figure 7 14: Leading Competitors, Orthopedic Cell Therapy Market, U.S., 2016
Figure 8 1: Orthopedic Hyaluronic Acid Viscosupplementation Market by Segment, U.S., 2013 – 2023 (US$M)
Figure 8 2: Total Hyaluronic Acid Viscosupplementation Market, U.S., 2013 – 2023
Figure 8 3: Single-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 – 2023
Figure 8 4: Three-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 – 2023
Figure 8 5: Five-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 – 2023
Figure 8 6: Drivers and Limiters, Orthopedic Hyaluronic Acid Viscosupplementation Market, U.S., 2016
Figure 8 7: Leading Competitors, Orthopedic Hyaluronic Acid Viscosupplementation Market, U.S., 2016
Figure 9 1: Orthopedic Cartilage Repair Market by Segment, U.S., 2013 – 2023 (US$M)
Figure 9 2: Osteochondral Allograft Market, U.S., 2013 – 2023
Figure 9 3: Meniscal Allograft Market, U.S., 2013 – 2023
Figure 9 4: Autologous Chondrocyte Implantation Market, U.S., 2013 – 2023
Figure 9 5: Particulated Juvenile Allograft Implant Market, U.S., 2013 – 2023
Figure 9 6: Microfracture Adjunct Market, U.S., 2013 – 2023
Figure 9 7: Drivers and Limiters, Orthopedic Cartilage Repair Market, U.S., 2016
Figure 9 8: Leading Competitors, Orthopedic Cartilage Repair Market, U.S., 2016
Figure 10 1: Spinal Machined Bone Allograft Market by Segment, U.S., 2013 – 2023 (US$M)
Figure 10 2: Total Spinal Machined Bone Allograft Market, U.S., 2013 – 2023
Figure 10 3: ALIF Machined Bone Allograft Market, U.S., 2013 – 2023
Figure 10 4: PLIF Machined Bone Allograft Market, U.S., 2013 – 2023
Figure 10 5: TLIF Machined Bone Allograft Market, U.S., 2013 – 2023
Figure 10 6: CIF Machined Bone Allograft Market, U.S., 2013 – 2023
Figure 10 7: Drivers and Limiters, Spinal Machined Bone Allograft Market, U.S., 2016
Figure 10 8: Leading Competitors, Spinal Machined Bone Allograft Market, U.S., 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report